Gastric Cancer Diagnostic Procedure Industry Insights: Market Forecast to 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Larger Is The Gastric Cancer Diagnostic Procedure Market Expected To Become By 2029 Compared With Its 2025 Level?

The gastric cancer diagnostic procedure market has observed robust growth in recent years. It is anticipated to expand from $1.44 billion in 2024 to $1.54 billion in 2025, achieving a compound annual growth rate (CAGR) of 7.1%. The historical increase can be ascribed to advancements in biopsy techniques, a boost in research funding, the development of biomarker discovery, refined pathological analysis, and modifications in screening guidelines.

The gastric cancer diagnostic procedure market is projected for substantial expansion in the coming years. Its valuation is set to reach $2.06 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.5%. This anticipated growth is driven by factors such as an increase in point-of-care testing, the emergence of new biomarkers, a move towards personalized medicine, the incorporation of next-generation sequencing, and improvements in endoscopic imaging modalities. Key developments expected during this forecast period encompass the integration of nanotechnology, the embrace of big data analytics, the utilization of microbiota analysis, a heightened focus on patient-centric methodologies, and the evolving role of telehealth in diagnostics.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12038&type=smp

Which Factors And Drivers Are Influencing The Gastric Cancer Diagnostic Procedure Market In 2025?

The escalating prevalence of gastrointestinal diseases is a primary catalyst for the growth of the gastric cancer diagnostic procedure market. Gastrointestinal disorders are defined as conditions impacting various segments of the digestive system and its auxiliary organs, such as the liver and pancreas. A gastric cancer diagnostic procedure, employing techniques like endoscopy and biopsy, is essential for detecting stomach cancer. The rising occurrence of these illnesses is thus fueling the expansion of the gastric cancer diagnostic procedure market. For example, in August 2022, a report from GI Associates & Endoscopy Center, a US-based medical facility dedicated to gastroenterology services, cited a study comprising 73,076 people from 33 nations, which found that 40% of the participants experienced a functional gastrointestinal illness. The increasing frequency of gastrointestinal diseases, therefore, directly drives the advancement of the gastric cancer diagnostic procedure market.

How Is The Gastric Cancer Diagnostic Procedure Market Segmented?

The gastric cancer diagnostic proceduremarket covered in this report is segmented –

1) By Procedure Type: Endoscopic Procedure; Biopsy; Tissue Tests; Lab Tests; In-Vitro Diagnostic Tests; Imaging Tests; Molecular Diagnostics; Multiplexing Molecular Diagnostics; Immunoassays; Other Procedure Types

2) By Symptom Type: Symptomatic; Asymptomatic

3) By Offering Type: Instruments; Reagents And Consumables; Services

4) By Body Fluid Type: Blood; Urine; Saliva; Stomach Juice; Tissue; Other Body Fluid

5) By Disease Indication: Early Gastric Cancer; Advanced Gastric Cancer

Subsegments:

1) By Endoscopic Procedure: Upper Endoscopy (EGD); Endoscopic Ultrasound (EUS)

2) By Biopsy: Endoscopic Biopsy; Fine Needle Aspiration (FNA) Biopsy

3) By Tissue Tests: Histopathology; Immunohistochemistry

4) By Lab Tests: Blood Tests; Tumor Markers

5) By In-Vitro Diagnostic Tests: Genetic Testing; Molecular Profiling

6) By Imaging Tests: Computed Tomography (CT) Scan; Magnetic Resonance Imaging (MRI); Positron Emission Tomography (PET) Scan

7) By Molecular Diagnostics: PCR Testing; Next-Generation Sequencing (NGS)

8) By Multiplexing Molecular Diagnostics: Multiplex PCR; Microarray Analysis

9) By Immunoassays: Enzyme-Linked Immunosorbent Assay (ELISA); Radioimmunoassay (RIA)

10) By Other Procedure Types: Breath Tests; Liquid Biopsies

Which Competitive Trends Are Defining The Gastric Cancer Diagnostic Procedure Market Structure?

Technological progress is a prominent and increasingly popular trend within the gastric cancer diagnostic market. To preserve their market presence, prominent companies in the gastric cancer diagnostic market are embracing new technologies. For example, in June 2022, Ibex Medical Analytics, an Israeli company specializing in AI-driven diagnostics for healthcare entities, introduced Galen Gastric, which is the globe’s inaugural AI-based product designed for detecting gastric cancer. This integrated diagnostic instrument, Galen Gastric, assists pathologists in pinpointing stomach cancer, H. pylori, and various other crucial clinical observations, concurrently enabling faster processing and refined diagnostic procedures.

Which Global Market Leaders Are Shaping The Future Of The Gastric Cancer Diagnostic Procedure Sector?

Major companies operating in the gastric cancer diagnostic procedure market include Pfizer Inc., Johnson & Johnson Co, F. Hoffmann La Roche Ltd., Merck & Co. Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca plc, Abbott Laboratories Inc., Sanofi SA, Eli Lilly and Company, Otsuka Pharmaceutical Co Ltd., AdventHealth, Atrium Health, Astellas Pharma Inc, Bausch Health Companies Inc., Agilent Technologies Inc., Ipsen Pharma, Hartford HealthCare, Myriad Genetics Inc., NovoCure Limited, Foundation Medicine Inc., Biocept Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/gastric-cancer-diagnostic-procedure-global-market-report

How Do Regional Market Performances Compare Within The Gastric Cancer Diagnostic Procedure Industry?

North America was the largest region in the gastric cancer diagnostics procedure market in 2024. The regions covered in the gastric cancer diagnostic procedure market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Gastric Cancer Diagnostic Procedure Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12038&type=smp

Browse Through More Reports Similar to the Global Gastric Cancer Diagnostic Procedure Market 2025, By The Business Research Company

Transportation Manufacturing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/transportation-manufacturing-global-market-report

Truck Transportation Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/truck-transportation-global-market-report

Commercial Vehicle Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/commercial-vehicle-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795